Acadia Pharmaceuticals Taps Bristol Myers Squibb Veteran as New Chief Commercial Officer
Acadia Pharmaceuticals (NASDAQ: ACAD) has appointed Thomas Andrew Garner as Chief Commercial Officer, effective immediately. Garner brings over 25 years
Read More